Grifols (GIKLY) Gains from Investment Securities (2010 - 2021)

Grifols (GIKLY) reported Gains from Investment Securities of $17.2 million for Q4 2021, down 15.18% on a YoY basis from $20.3 million in Q4 2020, and down 15.18% quarter-over-quarter from $20.3 million in Q4 2020.

Grifols (GIKLY) Gains from Investment Securities (2010 - 2021) Analysis & Trends

Grifols has reported Gains from Investment Securities for 11 years, with the latest figure at $17.2 million in Q4 2021.

  • For the quarter ending Q4 2021, Gains from Investment Securities fell 15.18% year-over-year to $17.2 million; the trailing twelve-month figure through Dec 2021 stood at $17.2 million (down 15.18% YoY), and the FY2025 full-year result was -$2.3 million, down 117.86% from the prior year.
  • Gains from Investment Securities for Q4 2021 stood at $17.2 million, down from $20.3 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $20.3 million in Q4 2020, with the low at $13.2 million in Q2 2017.
  • Historically, Gains from Investment Securities has averaged $15.8 million across 4 years, with a median of $14.2 million in 2018.
  • Annual changes were most pronounced in 2017 — Gains from Investment Securities sank 88.65% — and 2018, when it advanced 7.95%.
  • Grifols' Gains from Investment Securities stood at $13.9 million in 2017, then grew by 2.26% to $14.2 million in 2018, then surged by 42.46% to $20.3 million in 2020, then slipped by 15.18% to $17.2 million in 2021.
  • The last three Gains from Investment Securities figures came in at $17.2 million (Q4 2021), $20.3 million (Q4 2020), and $14.2 million (Q2 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2021 17.20 Mn
Dec 31, 2021 17.20 Mn
Dec 31, 2020 20.28 Mn
Dec 31, 2020 20.28 Mn
Jun 30, 2018 14.23 Mn
Jun 30, 2018 14.23 Mn
Dec 31, 2017 13.92 Mn
Dec 31, 2017 13.92 Mn
Jun 30, 2017 13.19 Mn
Jun 30, 2017 13.19 Mn
Dec 31, 2016 122.64 Mn
Dec 31, 2016 122.64 Mn
Sep 30, 2016 13.71 Mn
Sep 30, 2016 13.71 Mn
Jun 30, 2016 14.26 Mn
Jun 30, 2016 14.26 Mn
Dec 31, 2015 -150.85 Mn
Dec 31, 2015 -150.85 Mn
Sep 30, 2015 81.12 Mn
Sep 30, 2015 81.12 Mn